[
  {
    "ts": null,
    "headline": "Top Analyst Reports for NVIDIA, AT&T & Amgen",
    "summary": "NVIDIA's data center gains, AT&T's wireless momentum, and Amgen's product strength headline today's standout analyst reports.",
    "url": "https://finnhub.io/api/news?id=c31c96e66be5231b69e46bb007638246f9cc68d23ce7817b54954ce592dbf07b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764107040,
      "headline": "Top Analyst Reports for NVIDIA, AT&T & Amgen",
      "id": 137611391,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "NVIDIA's data center gains, AT&T's wireless momentum, and Amgen's product strength headline today's standout analyst reports.",
      "url": "https://finnhub.io/api/news?id=c31c96e66be5231b69e46bb007638246f9cc68d23ce7817b54954ce592dbf07b"
    }
  },
  {
    "ts": null,
    "headline": "Arrowhead Pharmaceuticals Reports 2025 Fiscal Year-End Results",
    "summary": "PASADENA, Calif., November 25, 2025--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2025 fiscal year ended September 30, 2025. The Company is hosting a conference call today, November 25, 2025, at 4:30 p.m. ET to discuss the results.",
    "url": "https://finnhub.io/api/news?id=ad0ff38fcfb27114746dd682487098f20e466a750da4c00e933e3032f53b99c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764104400,
      "headline": "Arrowhead Pharmaceuticals Reports 2025 Fiscal Year-End Results",
      "id": 137611399,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "PASADENA, Calif., November 25, 2025--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2025 fiscal year ended September 30, 2025. The Company is hosting a conference call today, November 25, 2025, at 4:30 p.m. ET to discuss the results.",
      "url": "https://finnhub.io/api/news?id=ad0ff38fcfb27114746dd682487098f20e466a750da4c00e933e3032f53b99c8"
    }
  },
  {
    "ts": null,
    "headline": "1 Nasdaq 100 Stock Worth Your Attention and 2 We Brush Off",
    "summary": "The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing growth, increasing competition, or unsustainable valuations.",
    "url": "https://finnhub.io/api/news?id=0b0408c5986eb3725cbbc15120ab7e522e6ad2cf83ca0f7c3de1e3ad543bca32",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764095708,
      "headline": "1 Nasdaq 100 Stock Worth Your Attention and 2 We Brush Off",
      "id": 137611400,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing growth, increasing competition, or unsustainable valuations.",
      "url": "https://finnhub.io/api/news?id=0b0408c5986eb3725cbbc15120ab7e522e6ad2cf83ca0f7c3de1e3ad543bca32"
    }
  },
  {
    "ts": null,
    "headline": "Rigel Pharmaceuticals: Behind The Huge Rally",
    "summary": "Rigel Pharmaceuticals, Inc. posted a solid Q3 with robust sales growth. Discover insights on future profitability and market outlook. Click for this RIGL update.",
    "url": "https://finnhub.io/api/news?id=10fbd8308888c851886c7082538a7288263114dce4c7cb41a05476e07a17c038",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764093660,
      "headline": "Rigel Pharmaceuticals: Behind The Huge Rally",
      "id": 137607240,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1295160689/image_1295160689.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Rigel Pharmaceuticals, Inc. posted a solid Q3 with robust sales growth. Discover insights on future profitability and market outlook. Click for this RIGL update.",
      "url": "https://finnhub.io/api/news?id=10fbd8308888c851886c7082538a7288263114dce4c7cb41a05476e07a17c038"
    }
  },
  {
    "ts": null,
    "headline": "Is Amgen Stock Underperforming the Nasdaq?",
    "summary": "Amgen has underperformed the Nasdaq over the past year, but analysts are still fairly bullish about the biopharma stock's growth potential.",
    "url": "https://finnhub.io/api/news?id=a8d76c83694450e92b317bda53ea817082f301ea2f6b13ea8b15a0592ace9985",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764077559,
      "headline": "Is Amgen Stock Underperforming the Nasdaq?",
      "id": 137605955,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen has underperformed the Nasdaq over the past year, but analysts are still fairly bullish about the biopharma stock's growth potential.",
      "url": "https://finnhub.io/api/news?id=a8d76c83694450e92b317bda53ea817082f301ea2f6b13ea8b15a0592ace9985"
    }
  },
  {
    "ts": null,
    "headline": "Avantor® Receives 2025 Edison Patent Award for Sustainable Viral Inactivation Technology",
    "summary": "Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the Company, in partnership with Amgen, received a 2025 Edison Patent Award from the Research & Development Council of New Jersey. The recognition was for their pioneering development of a biodegradable detergent that enables safer, more sustainable viral inactivation in biomanufacturing.",
    "url": "https://finnhub.io/api/news?id=a9c8f7bda03d3cb6b39c3837d565f1aba93a658ed97ac6d02c365e056d7d0061",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764075900,
      "headline": "Avantor® Receives 2025 Edison Patent Award for Sustainable Viral Inactivation Technology",
      "id": 137605956,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the Company, in partnership with Amgen, received a 2025 Edison Patent Award from the Research & Development Council of New Jersey. The recognition was for their pioneering development of a biodegradable detergent that enables safer, more sustainable viral inactivation in biomanufacturing.",
      "url": "https://finnhub.io/api/news?id=a9c8f7bda03d3cb6b39c3837d565f1aba93a658ed97ac6d02c365e056d7d0061"
    }
  },
  {
    "ts": null,
    "headline": "Investors in Amgen (NASDAQ:AMGN) have seen decent returns of 76% over the past five years",
    "summary": "When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than...",
    "url": "https://finnhub.io/api/news?id=2c779e06ccfa542cbdc3bb65e60560da6747e550fe6ec5076265a1ec7172117c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764072021,
      "headline": "Investors in Amgen (NASDAQ:AMGN) have seen decent returns of 76% over the past five years",
      "id": 137605957,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than...",
      "url": "https://finnhub.io/api/news?id=2c779e06ccfa542cbdc3bb65e60560da6747e550fe6ec5076265a1ec7172117c"
    }
  }
]